IdentificationGeneric Name(1S,3S,5S)-2-{(2S)-2-amino-2-[(1R,3S,5R,7S)-3-hydroxytricyclo[3.3.1.1~3,7~]dec-1-yl]acetyl}-2-azabicyclo[3.1.0]hexane-3-carbonitrileDrugBank Accession NumberDB07465BackgroundNot AvailableTypeSmall MoleculeGroupsExperimentalStructure


Download MOLSDFPDBSMILESInChI


 Similar StructuresStructure for (1S,3S,5S)-2-{(2S)-2-amino-2-[(1R,3S,5R,7S)-3-hydroxytricyclo[3.3.1.1~3,7~]dec-1-yl]acetyl}-2-azabicyclo[3.1.0]hexane-3-carbonitrile (DB07465)× CloseWeightAverage: 315.41 Monoisotopic: 315.194677059 Chemical FormulaC18H25N3O2SynonymsNot AvailablePharmacologyIndicationNot AvailableReduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.See how  Build, train, & validate predictive machine-learning models with structured datasets.See howContraindications & Blackbox WarningsAvoid life-threatening adverse drug eventsImprove clinical decision support with information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Learn more  Avoid life-threatening adverse drug events & improve clinical decision support.Learn morePharmacodynamicsNot AvailableMechanism of actionTargetActionsOrganismUDipeptidyl peptidase 4Not AvailableHumansAbsorptionNot AvailableVolume of distributionNot AvailableProtein bindingNot AvailableMetabolismNot AvailableRoute of eliminationNot AvailableHalf-lifeNot AvailableClearanceNot AvailableAdverse EffectsImprove decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates.Learn more  Improve decision support & research outcomes with our structured adverse effects data.Learn moreToxicityNot AvailablePathwaysNot AvailablePharmacogenomic Effects/ADRs 


Not AvailableInteractionsDrug Interactions 


This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist. Not AvailableFood InteractionsNot AvailableCategoriesDrug CategoriesNot AvailableChemical TaxonomyProvided by ClassyfireDescriptionThis compound belongs to the class of organic compounds known as alpha amino acid amides. These are amide derivatives of alpha amino acids.KingdomOrganic compoundsSuper ClassOrganic acids and derivativesClassCarboxylic acids and derivativesSub ClassAmino acids, peptides, and analoguesDirect ParentAlpha amino acid amidesAlternative ParentsN-acylpiperidines / N-acylpyrrolidines / Tertiary carboxylic acid amides / Tertiary alcohols / Cyclic alcohols and derivatives / Nitriles / Azacyclic compounds / Organopnictogen compounds / Organic oxides / Monoalkylamines / Hydrocarbon derivatives / Carbonyl compounds


 show 2 moreSubstituentsAlcohol / Aliphatic heteropolycyclic compound / Alpha-amino acid amide / Amine / Azacycle / Carbonitrile / Carbonyl group / Carboxamide group / Cyclic alcohol / Hydrocarbon derivative / N-acyl-piperidine / N-acylpyrrolidine / Nitrile / Organic nitrogen compound / Organic oxide / Organic oxygen compound / Organoheterocyclic compound / Organonitrogen compound / Organooxygen compound / Organopnictogen compound / Piperidine / Primary aliphatic amine / Primary amine / Pyrrolidine / Tertiary alcohol / Tertiary carboxylic acid amide


 show 16 moreMolecular FrameworkAliphatic heteropolycyclic compoundsExternal DescriptorsNot AvailableAffected organismsNot AvailableChemical IdentifiersUNIINot AvailableCAS numberNot AvailableInChI KeyQGJUIPDUBHWZPV-YQBUGCKMSA-NInChIInChI=1S/C18H25N3O2/c19-8-13-2-12-3-14(12)21(13)16(22)15(20)17-4-10-1-11(5-17)7-18(23,6-10)9-17/h10-15,23H,1-7,9,20H2/t10-,11+,12-,13+,14+,15-,17+,18-/m1/s1IUPAC Name(1S,3S,5S)-2-[(2S)-2-amino-2-[(1r,3R,5R,7S)-3-hydroxyadamantan-1-yl]acetyl]-2-azabicyclo[3.1.0]hexane-3-carbonitrileSMILES[H][C@@](N)(C(=O)N1[C@@]2([H])C[C@@]2([H])C[C@@]1([H])C#N)[C@]12C[C@@]3([H])C[C@]([H])(C[C@](O)(C3)C1)C2ReferencesGeneral ReferencesNot AvailableExternal LinksPubChem Compound11235729PubChem Substance99443936ChemSpider25027173ZINCZINC000100035546PDBe LigandBJMPDB Entries3bjmClinical TrialsClinical Trials 


PhaseStatusPurposeConditionsCountPharmacoeconomicsManufacturersNot AvailablePackagersNot AvailableDosage FormsNot AvailablePricesNot AvailablePatentsNot AvailablePropertiesStateSolidExperimental PropertiesNot AvailablePredicted PropertiesPropertyValueSourceWater Solubility2.26 mg/mLALOGPSlogP0.88ALOGPSlogP-0.08ChemaxonlogS-2.1ALOGPSpKa (Strongest Acidic)14.74ChemaxonpKa (Strongest Basic)7.9ChemaxonPhysiological Charge1ChemaxonHydrogen Acceptor Count4ChemaxonHydrogen Donor Count2ChemaxonPolar Surface Area90.35 Å2ChemaxonRotatable Bond Count2ChemaxonRefractivity83.99 m3·mol-1ChemaxonPolarizability33.87 Å3ChemaxonNumber of Rings5ChemaxonBioavailability1ChemaxonRule of FiveYesChemaxonGhose FilterYesChemaxonVeber's RuleNoChemaxonMDDR-like RuleNoChemaxonPredicted ADMET FeaturesPropertyValueProbabilityHuman Intestinal Absorption+0.9894Blood Brain Barrier+0.8823Caco-2 permeable-0.5446P-glycoprotein substrateSubstrate0.5909P-glycoprotein inhibitor INon-inhibitor0.696P-glycoprotein inhibitor IINon-inhibitor0.7875Renal organic cation transporterNon-inhibitor0.7903CYP450 2C9 substrateNon-substrate0.8618CYP450 2D6 substrateNon-substrate0.7519CYP450 3A4 substrateSubstrate0.5944CYP450 1A2 substrateNon-inhibitor0.8448CYP450 2C9 inhibitorNon-inhibitor0.8017CYP450 2D6 inhibitorNon-inhibitor0.8198CYP450 2C19 inhibitorNon-inhibitor0.81CYP450 3A4 inhibitorNon-inhibitor0.8641CYP450 inhibitory promiscuityLow CYP Inhibitory Promiscuity0.9032Ames testNon AMES toxic0.7569CarcinogenicityNon-carcinogens0.9122BiodegradationNot ready biodegradable1.0Rat acute toxicity2.7529 LD50, mol/kg Not applicablehERG inhibition (predictor I)Weak inhibitor0.9912hERG inhibition (predictor II)Non-inhibitor0.832  ADMET data is predicted using admetSAR, a free tool for evaluating chemical ADMET properties. (23092397) SpectraMass Spec (NIST)Not AvailableSpectraSpectrumSpectrum TypeSplash KeyPredicted GC-MS Spectrum - GC-MSPredicted GC-MSNot AvailablePredicted MS/MS Spectrum - 10V, Positive (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 20V, Positive (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 40V, Positive (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 10V, Negative (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 20V, Negative (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 40V, Negative (Annotated)Predicted LC-MS/MSNot AvailableTargetsBuild, predict & validate machine-learning modelsUse our structured and evidence-based datasets to unlock newinsights and accelerate drug research.Learn more  Use our structured and evidence-based datasets to unlock new insights and accelerate drug research.Learn more


 Details1. Dipeptidyl peptidase 4KindProteinOrganismHumansPharmacological actionUnknownGeneral FunctionVirus receptor activitySpecific FunctionCell surface glycoprotein receptor involved in the costimulatory signal essential for T-cell receptor (TCR)-mediated T-cell activation. Acts as a positive regulator of T-cell coactivation, by bindi...Gene NameDPP4Uniprot IDP27487Uniprot NameDipeptidyl peptidase 4Molecular Weight88277.935 DaReferencesBerman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. [Article] ×Identify potential medication risksEasily compare up to 40 drugs with our drug interaction checker.Get severity rating, description, and management advice. Learn more   Drug created at September 15, 2010 21:22 / Updated at June 12, 2020 16:52 